Mrv1909 12152020032D 8 8 0 0 0 0 999 V2000 0.7145 2.0625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 0.8250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 -0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -0.4125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 2 0 0 0 0 4 6 1 0 0 0 0 6 7 1 0 0 0 0 7 8 2 0 0 0 0 2 8 1 0 0 0 0 M ISO 1 4 13 M END > DB16345 > drugbank > O=C1N[13C](=O)NC=C1 > InChI=1S/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8)/i4+1 > ISAKRJDGNUQOIC-AZXPZELESA-N > C4H4N2O2 > 113.08 > 113.030632212 > 2 > 12 > -0.015482310521306036 > 9.365498888887565 > 1 > 2 > 0 > 0 > 1,2,3,4-tetrahydro(2-13C)pyrimidine-2,4-dione > -1.20 > -0.8552909999999998 > -0.63 > 0 > 0 > 1 > 0 > 13.75667787006284 > 8.803392786213806 > -5.5116186106121114 > 58.2 > 25.969299999999997 > 0 > 1 > 2.65e+01 g/l > 8-[(3R)-3-[1-({1-[(E)-{[(7S,9E,11S,12S,13S,14S,15R,16R,17S,18S,19E)-13-(acetyloxy)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1^{4,7}.0^{5,28}]triaconta-1(28),2,4,9,19,21,25(29),26-octaen-26-yl]methylidene}amino]piperidin-4-yl}(methyl)amino)cyclopropyl]pyrrolidin-1-yl]-1-cyclopropyl-7-fluoro-9-methyl-4-oxoquinolizine-3-carboxylic acid > 0 > DB16345 > investigational > Uracil C-13 > 13C-uracil; Uracil (2-13c); Uracil 2c-13; Uracil C-13, 2-; Uracil-(2-13c) $$$$